anti-HER2 antibody (Merck)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-HER2 antibody (Merck)
Drug Alias Nametrastuzumab biobetter (Merck Bioventures)anti-HER2 antibody (Glycofi)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Bioventures
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Bioventures
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A